ADMA News and Press, ADMA Biologics Inc From 05/09/24

2024-05-09 23:11:09 ET ADMA Biologics, Inc. (ADMA) Q1 2024 Earnings Conference Call May 09, 2024, 04:30 AM ET Company Participants Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Grossman - President and CEO Brian Lenz - Executive...

2024-05-09 16:23:40 ET More on ADMA Biologics Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade) ADMA Biologics, Inc. (ADMA) Q4 2023 Earnings Call Transcript ADMA Biologics Q1 2024 Earnings Preview ADMA Biologics' CFO to step dow...

1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y 1Q 2024 Adjusted EBITDA ( 1 ) of $26.4 Million, a 970% Increase Y-o-Y FY 2024 and 2025 Total Revenue Guidance...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

2024-05-08 17:20:08 ET More on ADMA Biologics Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade) ADMA Biologics, Inc. (ADMA) Q4 2023 Earnings Call Transcript ADMA Biologics' CFO to step down ADMA Biologics GAAP EPS of -$0.08 miss...

2024-05-06 12:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RAMSEY, N.J. and BOCA RATON, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announ...

2024-04-28 04:39:02 ET Summary Today, we look at three small-cap biotech/biopharma stocks. All three have attractive risk/reward profiles and potential catalysts on the horizon. An investment synopsis on all three firms is presented in the paragraphs below. Today, we...

2024-04-26 19:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-16 21:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...